Literature DB >> 10224277

Effect of factor XIII on endothelial barrier function.

T Noll1, G Wozniak, K McCarson, A Hajimohammad, H J Metzner, J Inserte, W Kummer, F W Hehrlein, H M Piper.   

Abstract

The effect of factor XIII on endothelial barrier function was studied in a model of cultured monolayers of porcine aortic endothelial cells and saline-perfused rat hearts. The thrombin-activated plasma factor XIII (1 U/ml) reduced albumin permeability of endothelial monolayers within 20 min by 30 +/- 7% (basal value of 5.9 +/- 0.4 x 10(-6) cm/s), whereas the nonactivated plasma factor XIII had no effect. Reduction of permeability to the same extent, i.e., by 34 +/- 9% could be obtained with the thrombin-activated A subunit of factor XIII (1 U/ml), whereas the iodoacetamide-inactivated A subunit as well as the B subunit had no effect on permeability. Endothelial monolayers exposed to the activated factor XIII A exhibited immunoreactive deposition of itself at interfaces of adjacent cells; however, these were not found on exposure to nonactivated factor XIII A or factor XIII B. Hyperpermeability induced by metabolic inhibition (1 mM potassium cyanide plus 1 mM 2-deoxy-D-glucose) was prevented in the presence of the activated factor XIII A. Likewise, the increase in myocardial water content in ischemic-reperfused rat hearts was prevented in its presence. This study shows that activated factor XIII reduces endothelial permeability. It can prevent the loss of endothelial barrier function under conditions of energy depletion. Its effect seems related to a modification of the paracellular passageways in endothelial monolayers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10224277      PMCID: PMC2193057          DOI: 10.1084/jem.189.9.1373

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

Review 1.  Factor XIII: enzymatic and clinical aspects.

Authors:  H E Karges; R Clemens
Journal:  Behring Inst Mitt       Date:  1988-04

2.  Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.

Authors:  D F Mosher; P E Schad
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

3.  Permeability characteristics of cultured endothelial cell monolayers.

Authors:  S M Albelda; P M Sampson; F R Haselton; J M McNiff; S N Mueller; S K Williams; A P Fishman; E M Levine
Journal:  J Appl Physiol (1985)       Date:  1988-01

4.  Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.

Authors:  H Kamitsuji; K Tani; M Yasui; A Taniguchi; K Taira; S Tsukada; Y Iida; H Kanki; H Fukui
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

5.  Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor.

Authors:  C G Curtis; K L Brown; R B Credo; R A Domanik; A Gray; P Stenberg; L Lorand
Journal:  Biochemistry       Date:  1974-08-27       Impact factor: 3.162

6.  Human factor XIII: fibrin-stabilizing factor.

Authors:  L Lorand; M S Losowsky; K J Miloszewski
Journal:  Prog Hemost Thromb       Date:  1980

7.  Factor XIII cross-linking of fibronectin at cellular matrix assembly sites.

Authors:  E L Barry; D F Mosher
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

8.  The lack of attachment of transformed embryonic lung epithelial cells to collagen I is corrected by fibronectin and FXIII.

Authors:  M Paye; C M Lapière
Journal:  J Cell Sci       Date:  1986-12       Impact factor: 5.285

9.  Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.

Authors:  U Sibelius; K Hattar; A Schenkel; T Noll; E Csernok; W L Gross; W J Mayet; H M Piper; W Seeger; F Grimminger
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

10.  Role of fibronectin in the migration of fibroblasts into plasma clots.

Authors:  P Knox; S Crooks; C S Rimmer
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

View more
  16 in total

1.  Recombinant factor XIII mitigates hemorrhagic shock-induced organ dysfunction.

Authors:  Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Inga V Malinina; Edwin A Deitch; Eva H Olsen
Journal:  J Surg Res       Date:  2010-12-31       Impact factor: 2.192

Review 2.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

3.  Plasmatic [corrected] factor XIII reduces severe pleural effusion in children after open-heart surgery.

Authors:  M Schroth; U Meißner; R Cesnjevar; M Weyand; H Singer; W Rascher; J Klinge
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

Review 4.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

5.  Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients.

Authors:  Marina Marchetti; Patricia Gomez-Rosas; Laura Russo; Sara Gamba; Eleonora Sanga; Cristina Verzeroli; Chiara Ambaglio; Francesca Schieppati; Francesco Restuccia; Ezio Bonanomi; Marco Rizzi; Stefano Fagiuoli; Andrea D'Alessio; Grigorios T Gerotziafas; Luca Lorini; Anna Falanga
Journal:  Front Cardiovasc Med       Date:  2022-06-10

6.  Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase.

Authors:  Muhammad Aslam; Klaus-Dieter Schluter; Susanne Rohrbach; Amir Rafiq; Sabiha Nazli; Hans Michael Piper; Thomas Noll; Rainer Schulz; Dursun Gündüz
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

7.  Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury.

Authors:  Sergey B Zaets; Da-Zhong Xu; Qi Lu; Eleonora Feketova; Tamara L Berezina; Maryann Gruda; Inga V Malinina; Edwin A Deitch; Eva H N Olsen
Journal:  Shock       Date:  2009-06       Impact factor: 3.454

8.  Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability.

Authors:  Uwe Pfeil; Muhammad Aslam; Renate Paddenberg; Karin Quanz; Chia L Chang; Jae-Il Park; Barbara Gries; Amir Rafiq; Petra Faulhammer; Anna Goldenberg; Tamara Papadakis; Thomas Noll; Sheau Y T Hsu; Norbert Weissmann; Wolfgang Kummer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-14       Impact factor: 5.464

9.  Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.

Authors:  Essi Myrsky; Sergio Caja; Zsofi Simon-Vecsei; Ilma R Korponay-Szabo; Cristina Nadalutti; Russell Collighan; Alexandre Mongeot; Martin Griffin; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2009-08-13       Impact factor: 9.261

10.  Glycolysis is integral to histamine-induced endothelial hyperpermeability.

Authors:  Athanasios Ziogas; Md Sanaullah Sajib; Jong-Hyung Lim; Tiago C Alves; Anupam Das; Anke Witt; Eman Hagag; Nikolais Androulaki; Sylvia Grossklaus; Michael Gerlach; Thomas Noll; Tatyana Grinenko; Peter Mirtschink; George Hajishengallis; Triantafyllos Chavakis; Constantinos M Mikelis; David Sprott
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.